You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CAR-T Cells Therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapse/Refractory Multiple Myeloma Trial in Hangzhou (DeepTag-GPRC5D Targeted CAR T-cells)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • DeepTag-GPRC5D Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The first affiliated hospital of medical college of zhejiang uni
Oct 10, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial (Anti-GPRC5D CAR-T Cells Injection)

Not yet recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T Cells Injection
  • (no location specified)
Feb 18, 2023

Recurrent Glioblastoma Multiforme Trial in Beijing (SNC-109 CAR-T Cells)

Recruiting
  • Recurrent Glioblastoma Multiforme
  • SNC-109 CAR-T Cells
  • Beijing, China
    Chinese PLA General Hospital
May 11, 2023

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Kunming (Anti-GPRC5D CAR-T cells infusion)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • Anti-GPRC5D CAR-T cells infusion
  • Kunming, Yunnan, China
  • +1 more
Feb 21, 2023

Relapse Multiple Myeloma, Refractory Multiple Myeloma Trial in Hangzhou (BCMA Targeted CAR T-cells)

Recruiting
  • Relapse Multiple Myeloma
  • Refractory Multiple Myeloma
  • BCMA Targeted CAR T-cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, Medical College, Zhejiang Univers
Jun 18, 2022

Advanced Solid Tumor Trial in Lianyungang (KT095 CAR-T injection)

Not yet recruiting
  • Advanced Solid Tumor
  • KT095 CAR-T injection
  • Lianyungang, Jiangsu, China
    Lianyungang First People's Hospital
Aug 23, 2022

B-cell Acute Lymphoblastic Leukemia, Lymphoblastic B-Cell Lymphoma Trial in Minsk (CD19 CAR-T-cells, Tocilizumab)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • Lymphoblastic B-Cell Lymphoma
  • Minsk, Minsk Region, Belarus
    Belarussian Research Center for Pediatric Oncology, Hematology a
Apr 12, 2022

Advanced Solid Tumors, Gastric Cancer, Esophagogastric Junction Cancer Trial in Beijing (IM92 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM92 CAR-T cells
  • Beijing, Beijing, China
    Chinese PLA GENERAL HOSPITAL
Mar 10, 2022

Multiple Myeloma in Relapse, Multiple Myeloma, Refractory Trial in Hangzhou (APRIL CAR-T cells)

Recruiting
  • Multiple Myeloma in Relapse
  • Multiple Myeloma, Refractory
  • APRIL CAR-T cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital，College of Medicine, Zhejiang Univ
May 3, 2022

Advanced Solid Tumors, Digestive System Tumors, Pancreatic Cancer Resectable Trial in Beijing (IM96 CAR-T cells)

Recruiting
  • Advanced Solid Tumors
  • +3 more
  • IM96 CAR-T cells
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Mar 10, 2022

Gastric Cancer, Colon Cancer, Pancreas Cancer Trial in Nanchang (CEA CAR-T cells)

Recruiting
  • Gastric Cancer
  • +6 more
  • CEA CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Carcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Duarte

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Autologous Anti-PSCA-CAR-4-1BB/TCRzeta-CD19t-expressing T-lymphocytes
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Apr 5, 2023

Multiple Myeloma Trial (BMCA and GPRC5D dual target CAR-T cells(OriC321))

Not yet recruiting
  • Multiple Myeloma
  • BMCA and GPRC5D dual target CAR-T cells(OriC321)
  • (no location specified)
Apr 5, 2022

Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

Recruiting
  • Pancreas Cancer
  • +3 more
  • CAR-T cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Mar 10, 2023

Acute Myeloid Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia Trial in Duarte (Anti-CD33 CAR

Not yet recruiting
  • Acute Myeloid Leukemia
  • +3 more
  • Anti-CD33 CAR T-cells
  • Lymphodepletion Therapy
  • Duarte, California
    City of Hope Medical Center
Jan 3, 2023

Neuroendocrine Tumor (NET), Colorectal Cancer (CRC) Trial (CHM-2101 CAR-T cells)

Not yet recruiting
  • Neuroendocrine Tumor (NET)
  • Colorectal Cancer (CRC)
  • CHM-2101 CAR-T cells
  • (no location specified)
Sep 20, 2023

Mesothelin-positive Advanced Malignant Solid Tumors Trial (Anti-mesothelin CAR-T cells)

Not yet recruiting
  • Mesothelin-positive Advanced Malignant Solid Tumors
  • Anti-mesothelin CAR-T cells
  • (no location specified)
Mar 13, 2023

Multiple Myeloma, New Diagnosis Tumor Trial in Hangzhou (BCMA CAR-T cells)

Recruiting
  • Multiple Myeloma
  • New Diagnosis Tumor
  • BCMA CAR-T cells
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital, College of Medicine, Zhejiang Uni
Jan 31, 2023

Solid Tumor Trial in Shanghai (aPD1-MSLN-CAR T cells)

Recruiting
  • Solid Tumor
  • αPD1-MSLN-CAR T cells
  • Shanghai, Shanghai, China
    Shanghai Mengchao Cancer Hospital
Oct 24, 2022

SLE (Systemic Lupus) Trial in Bangkok (CAR T-cell therapy)

Not yet recruiting
  • SLE (Systemic Lupus)
  • CAR T-cell therapy
  • Bangkok, Please Select, Thailand
    King Chulalongkorn Memorial Hospital
Nov 23, 2023

Hematologic Malignancy, Large B-cell Lymphoma, Acute Lymphoblastic Leukemia Trial in Los Angeles (autologous hematopoietic stem

Not yet recruiting
  • Hematologic Malignancy
  • +5 more
  • autologous hematopoietic stem cells added to planned CAR T
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 31, 2023

Nasopharyngeal Carcinoma Trial (PK Blood Collection, CAR, TCR)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • PK Blood Collection
  • +2 more
  • (no location specified)
Nov 1, 2022

Lymphoma Trial in Seattle (biological, other, procedure)

Not yet recruiting
  • Lymphoma
  • Immune Globulin Infusion (Human), 10% Solution
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jul 21, 2023

SLE (Systemic Lupus), Sjogren's Syndrome, Systemic Scleroderma Trial in Taiyuan (CD19 targeted CAR-T cells)

Recruiting
  • SLE (Systemic Lupus)
  • +4 more
  • CD19 targeted CAR-T cells
  • Taiyuan, Shanxi, China
    Shanxi Bethune Hospital
Sep 25, 2023

CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

Recruiting
  • CAR-T Cell Therapy
  • GC012F injection
  • Shanghai, Shanghai, China
    Department of Rheumatology, Ren Ji Hospital South Campus, School
May 5, 2023